News: Law Enforcement Updates
November 2, 2026: HHS tells compounders it will not enforce peptide regulations
The policy effectively allows compounders to produce these drugs, which are massively understudied, even though they don't meet federal criteria for compounding.
Statement on the FDA and HHS enforcement discretion policy for 503a compounding with certain peptides
"Today's decision leaves Americans in a grey area as to whether peptides are safe or not, even though the FDA’s own scientists recommended against voting in favor of these substances due to concerns with evidence."
October 26, 2026: PSM files citizen petition asking FDA not to allow compounding of peptides
The peptides in question are untested and poorly defined, and making them easier to compound is a threat to public safety.
Case overview: Eli Lilly and Co v InstantRx, et al (2026 — ) – ongoing
Eli Lilly filed a complaint against InstantRx and other defendants that allegedly distributed counterfeit and/or misbranded versions of Lilly-branded medicines through online pharmacy to pharmacy marketplaces.
October 19, 2026: Two deaths linked to bootlegged retatrutide
Two deaths have been linked to black market versions of retatrutide, as a British woman warns followers that taking an early dose of the drug “nearly killed” her.
Partnership for Safe Medicines files Citizen Petition urging FDA to block compounding of unapproved and uncharacterized peptides
The Partnership for Safe Medicines (PSM) filed a citizen petition urging the U.S. Food and Drug Administration to block compounding of unapproved peptides and to disregard the advisory committee vote that recommended allowing them.
PSM files Citizen Petition with FDA to stop unsafe compounding of untested peptides
Partnership for Safe Medicines filed a citizen petition (CP) with the FDA asking them to refrain from taking action to allow for compounding of drug products using seven peptide bulk drug substances (BPC-157, KPV, TB-500, MOTS-c, emideltide, semax, and epitalon). Learn why here.
October 13, 2026: Mounting evidence that popular unapproved peptide causes cancers
Doctors reported that a man who injected the unregulated peptide he purchased at a gym developed a melanoma lesion after only taking the drug for five weeks.
Remembering Alex Boutin: the hidden risks of performance enhancing drugs
Alex took the advice of older gym veterans about how he could bulk up fast, setting off more than a decade of steroid and, eventually, unregulated peptide use.
Judgment, USA v Brandon Piper
United States District Court Western District of Michigan Southern Division USA v Brandon Piper Judgment July 24, 2026 Read the document.
